Differences in adipose tissue distribution of basic lipophilic drugs between intraperitoneal and other routes of administration

References

• Afifi A. -H. M., Wav E. L. Studies on the biologic disposition of methotrimeprazine. Journal of Pharmacology and Experimental Therapeutics 1968; 160: 397–406
   PubMedGoogle Scholar
• Bickel M. H. The role of adipose tissue in the distribution and storage of drugs. Progress in Drug Research 1984; 28: 273–303
   PubMedGoogle Scholar
• Bickel M. H., Graber B. E., Moor M. Distribution of chlorpromazine and imipramine in adipose tissue and other tissues of rats. Life Sciencef 1983; 33: 2025–2031
   PubMed Web of Science ®Google Scholar
• Bickel M. H., Weder H. J. The total fate of a drug: Kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine. Archives Internationales de Pharmacodynamie 1968a; 173: 433–463
   PubMedGoogle Scholar
• Bickel M. H., Weder H. J. Demethylation of imipramine in the rat as influenced by SKF 525-A and by different routes of administration. Life Sciences 1968b; 7: 1223–1230
   PubMedGoogle Scholar
• Chernov H. I., Woods L. A. Central nervous system distribution and metabolism of 14C-morphine during morphine-induced feline mania. Journal of Pharmacology and Experimental Therapeutics 1965; 149: 146–155
   PubMedGoogle Scholar
• Di Francesco C., Bickel M. H. Uptake in vitro of lipophilic model compounds into adipose tissue preparations and lipids. Biochemical Pharmacology 1985; 34: 3683–3688
   PubMed Web of Science ®Google Scholar
• Dubnick B., Towne C. A., Hartigan J. M., Phillips G. E. Distribution and metabolism of chIorphentermine-14C in rats and mice. Biochemical Pharmacology 1968; 17: 1243–1250
   PubMed Web of Science ®Google Scholar
• Elliott H. W., Chang F. N. H., Abdou I. A., Anderson H. H. The distribution of radioactivity in rats after administration of 14-C-labeled methadone. Journal of Pharmacology and Experimental Therapeutics 1949; 95: 495–501
   Google Scholar
• Eschenhof E., Rieder J. Untersuchungen ueber das Schicksal des Antidepressivums Amitriptylin im Organismus der Ratte und des Menschen. Arzneimittel-Forschung 1969; 19: 957–966
   PubMed Web of Science ®Google Scholar
• Forshell G. P. The distribution and excretion of ‘3H, 14C’ lofepramine in the rat. Xenobiotica 1975; 5: 73–82
   PubMed Web of Science ®Google Scholar
• Fuller R. W., Mlloy B. B., Roush B. W., Hauser K. M. Disposition and behavioral effects of amphetamine and β,β-difluoroamphetamine in mice. Biochemical Pharmacology 1972; 21: 1299–1307
   PubMedGoogle Scholar
• Gauch R., Michaelis W. The metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo b, e-1, 4-diazepine (clozapine) in mice, dogs and human subjects. Il Farmaco (ed. pratica) 1971; 26: 667–681
   PubMedGoogle Scholar
• Hansch C., Leo A. Substituent Constants for Correlation Analysis in Chemistry and Biology. John Wiley & Sons, New York 1979
   Google Scholar
• Harashima H., Sawada Y., Sugiyama Y., Iga T., Hanano M. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics. Journal of Pharmaco-kinetics and Biopharmaceutics 1985; 13: 425–440
   PubMedGoogle Scholar
• Herrmann B. Untersuchungen ueberden Stoffwechsel von Insidon. Arzneimittel-Forschung 1964; 14: 219–222
   PubMedGoogle Scholar
• Hucker H. B., Hutt J. E., White S. D., Arison B. H., Zacchei A. G. Disposition and metabolism of (+)-5-methyl-10, 11-dihydro-5H-dibenzo‘a, d’cyclohepten-5, 10-imine in rats, dogs, and monkeys. Drug Metabolism and Disposition 1983; 11: 54–58
   PubMedGoogle Scholar
• Ishitani R., Saito K., Kitagawa H. The pharmacological studies on dimetacrine. 1. Studies on the absorption, distribution and excretion of H3-labeled dimetacrine in the rat. Japanese Journal of Pharmacology 1970; 20: 432–438
   PubMedGoogle Scholar
• Jorgensen A., Fredericson K., Hansen V. Metabolism, distribution and excretion of flupenthixol decanoate in dogs and rats. Acta pharmacologica et toxicologica 1971; 29: 339–358
   PubMedGoogle Scholar
• Kamm J. J., Ferullo C. R., Miller D., van Loon E. J. Metabolism of chlorphentermine-3H by the rat and dog. Biochemical Pharmacology 1969; 18: 659–671
   PubMed Web of Science ®Google Scholar
• Kohl H. H., Brune G. G., Himwich H. E. A comparative study of chlorpromazine and its demethylated derivatives: potency and tissue distribution. Biochemical Pharmacology 1964; 13: 539–541
   PubMedGoogle Scholar
• Lewis R. E., Kunz A. L., Bell R. E. Error of intraperitoneal injections in rats. Laboratory Animal Care 1966; 16: 505–509
   PubMedGoogle Scholar
• Lukas G., Brindle S., Greengard P. Route of absorption of intraperitoneally administered compounds. Federation Proceedings 1967; 26: 615
   Google Scholar
• Marcucci R., Mussini E., Airoldi R., Faelli Frigerio A., De Nadai F., Bizzi A., Rizzo M., Morselli P. L., Garattini S. Analytical and pharmacokinetic studies on butyrophenones. Clinica Chimica Acta 1971; 34: 321–332
   PubMedGoogle Scholar
• Michaelis W. Zum Stoffwechsel von 5-methyl-β-)3-dimethylamino-aethyl-10, 11-dihydro-11-oxo-5H-dibenzo-‘b, e,’ ‘1, 4’-diazepin-HCl II. Resorption, Verteilung in den Organen und Aus- scheidung der mit 14C markierten Substanzen beim Tier. Arzneimittel-Forschung 1967; 17: 181–185
   Google Scholar
• Michaelis W. The metabolism of 2-chloro-11-(4-methyl-1-piperazinyl)dibenzo-‘b, f’‘1, 4’-thiazepine (clotiapine). I. Resorption, distribution in the body and excretion in rodents. Il Farmaco (ed. pratica) 1969; 24: 84–91
   PubMedGoogle Scholar
• Minder R., Schnetzer F., Bickel M. H. Hepatic and extrahepatic metabolism of the psychotropic drugs, chlorpromazine, imipramine, and imipramine-N-oxide. Archives of Pharmacology 1971; 268: 334–347
   PubMedGoogle Scholar
• Misra A. L., Block R., Vadlamani N. L., Mule S. J. Physiological disposition and biotransformation of levo-methadone-1-3H in the dog. Journal of Pharmacology and Experimental Therapeutics 1974; 188: 34–44
   PubMed Web of Science ®Google Scholar
• Misra A. L., Bloch R., Vadlamani N. L., Mule S. J. Laevo-‘1-3H’methadone disposition in tolerant dogs. Xenobiotica 1975; 5: 237–244
   PubMed Web of Science ®Google Scholar
• Natoff I. L. Influence of the route of administration on the toxicity of some cholinesterase inhibitors. Journal of Pharmacy and Pharmacology 1967; 19: 612–616
   PubMedGoogle Scholar
• Phillips B. M., Miya T. S. Disposition of 35S-prochlorperazine in the rat. Journal of Pharmaceutical Sciences 1964; 53: 1098–1101
   PubMedGoogle Scholar
• Rickards J. C., Boxer G. E., Smith C. C. Studies on the distribution and metabolism of methadone in normal and tolerant rats by a new colorimetric method. Journal of Pharmacology and Experimental Therapeutics 1950; 98: 380–391
   PubMed Web of Science ®Google Scholar
• Salzman N., Brodie B. B. Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 1956; 118: 46–54
   PubMedGoogle Scholar
• Schneider G., Schneider G., Bickel M. H. Ueber das Auftreten von Desmethylimipramin im Gehirn der Ratte nach Gabe von Imipraminin Abhaengigkeit von der Injektionsart. Psychopharmacologia (Berlin) 1969; 16: 156–160
   PubMedGoogle Scholar